Anna Gu

1.1k total citations
21 papers, 828 citations indexed

About

Anna Gu is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anna Gu has authored 21 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anna Gu's work include Blood Pressure and Hypertension Studies (5 papers), Nausea and vomiting management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Anna Gu is often cited by papers focused on Blood Pressure and Hypertension Studies (5 papers), Nausea and vomiting management (4 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Anna Gu collaborates with scholars based in United States, Spain and Switzerland. Anna Gu's co-authors include Edgar Argulian, Thomas Burke, Fadia T. Shaya, Yue Yu, Fausto Roila, Alex Molassiotis, Mario Dicato, Pere Gascón, Matti Aapro and Steven W. Blume and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The American Journal of Medicine.

In The Last Decade

Anna Gu

21 papers receiving 793 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Gu United States 10 474 245 120 108 103 21 828
Karl Miller Austria 19 1.1k 2.4× 282 1.2× 125 1.0× 29 0.3× 23 0.2× 52 1.4k
Jennifer Reynolds United States 11 86 0.2× 80 0.3× 45 0.4× 15 0.1× 49 0.5× 20 536
Reci Meseri Türkiye 17 90 0.2× 201 0.8× 35 0.3× 42 0.4× 56 0.5× 52 625
Craig R. Bailey United Kingdom 16 570 1.2× 147 0.6× 249 2.1× 151 1.4× 8 0.1× 81 1.3k
Barbara J. Zarowitz United States 13 71 0.1× 70 0.3× 49 0.4× 52 0.5× 18 0.2× 40 570
Cihan Kılıç Türkiye 17 102 0.2× 649 2.6× 44 0.4× 21 0.2× 10 0.1× 41 880
John B. Copley United States 16 159 0.3× 38 0.2× 42 0.3× 90 0.8× 11 0.1× 29 791
J W Yarnell United Kingdom 8 142 0.3× 108 0.4× 108 0.9× 14 0.1× 93 0.9× 11 727
Fumi Hirayama Australia 12 94 0.2× 106 0.4× 13 0.1× 177 1.6× 47 0.5× 34 654
Reid Whitlock Canada 19 129 0.3× 124 0.5× 161 1.3× 40 0.4× 4 0.0× 50 852

Countries citing papers authored by Anna Gu

Since Specialization
Citations

This map shows the geographic impact of Anna Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gu more than expected).

Fields of papers citing papers by Anna Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gu. The network helps show where Anna Gu may publish in the future.

Co-authorship network of co-authors of Anna Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Gu. A scholar is included among the top collaborators of Anna Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Gu. Anna Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gu, Anna, et al.. (2021). Factors Associated with COVID-19 Infection, Hospitalization and Death in New York City Neighborhoods. SHILAP Revista de lepidopterología. 12(3). 21–21. 2 indexed citations
2.
Gu, Anna, et al.. (2019). Trends and Disparities in Quality of Diabetes Care in the US: The National Health and Nutrition Examination Survey, 1999-2016. SHILAP Revista de lepidopterología. 10(4). 17–17. 9 indexed citations
3.
Gu, Anna, et al.. (2019). Patterns of Antihypertensive Drug Utilization among US Adults with Diabetes and Comorbid Hypertension: The National Health and Nutrition Examination Survey 1999-2014. Clinical Medicine Insights Cardiology. 13. 2771469754–2771469754. 6 indexed citations
4.
Gu, Anna, et al.. (2018). The Burden of Modifiable Risk Factors in Newly Defined Categories of Blood Pressure. The American Journal of Medicine. 131(11). 1349–1358.e5. 4 indexed citations
5.
Gu, Anna, et al.. (2018). Trends and disparities in statin use and low-density lipoprotein cholesterol levels among US patients with diabetes, 1999–2014. Diabetes Research and Clinical Practice. 139. 1–10. 29 indexed citations
6.
Gu, Anna, et al.. (2017). Racial and Ethnic Differences in Antihypertensive Medication Use and Blood Pressure Control Among US Adults With Hypertension. Circulation Cardiovascular Quality and Outcomes. 10(1). 112 indexed citations
7.
Gu, Anna, Yue Yu, & Edgar Argulian. (2015). Age Differences in Treatment and Control of Hypertension in US Physician Offices, 2003-2010: A Serial Cross-sectional Study. The American Journal of Medicine. 129(1). 50–58.e4. 21 indexed citations
8.
Gilmore, James, N. W. Peacock, Anna Gu, et al.. (2014). Antiemetic Guideline Consistency and Incidence of Chemotherapy-Induced Nausea and Vomiting in US Community Oncology Practice: INSPIRE Study. Journal of Oncology Practice. 10(1). 68–74. 142 indexed citations
9.
Molassiotis, Alex, Matti Aapro, Mario Dicato, et al.. (2013). Evaluation of Risk Factors Predicting Chemotherapy-Related Nausea and Vomiting: Results From a European Prospective Observational Study. Journal of Pain and Symptom Management. 47(5). 839–848.e4. 118 indexed citations
10.
Aapro, Matti, Alex Molassiotis, Mario Dicato, et al.. (2012). The effect of guideline-consistent antiemetic therapy on chemotherapy-induced nausea and vomiting (CINV): the Pan European Emesis Registry (PEER). Annals of Oncology. 23(8). 1986–1992. 219 indexed citations
11.
Gilmore, James, N. W. Peacock, Anna Gu, et al.. (2012). Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting (CINV) in U.S. community oncology practice: INSPIRE study.. Journal of Clinical Oncology. 30(34_suppl). 167–167. 2 indexed citations
12.
Gu, Anna, et al.. (2011). Drug Shortages in the US - Causes, Impact, and Strategies. SHILAP Revista de lepidopterología. 2(4). 14 indexed citations
13.
Signorovitch, James, Mei Sheng Duh, Anna Gu, et al.. (2009). Hospital visits and costs following outpatient treatment of CAP with levofloxacin or moxifloxacin. Current Medical Research and Opinion. 26(2). 355–363. 2 indexed citations
14.
Shaya, Fadia T., Anna Gu, & Yan Xia. (2008). Effect of Persistence with Drug Therapy On the Risk of Myocardial Re-infarction.. PubMed. 33(5). 288–95. 3 indexed citations
15.
Shaya, Fadia T., Anna Gu, & Elijah Saunders. (2007). Metabolic syndrome prevalence in an urban African American population. Diabetes & Metabolic Syndrome Clinical Research & Reviews. 1(3). 151–157. 4 indexed citations
16.
Shaya, Fadia T. & Anna Gu. (2007). Critical assessment of intent-to-treat analyses. Journal of Medical Economics. 10(2). 171–177. 7 indexed citations
17.
Shaya, Fadia T. & Anna Gu. (2006). Deriving effectiveness information for decision-making. Expert Review of Pharmacoeconomics & Outcomes Research. 6(1). 5–7. 1 indexed citations
18.
Shaya, Fadia T., Anna Gu, & Elijah Saunders. (2006). ADDRESSING CARDIOVASCULAR DISPARITIES THROUGH COMMUNITY INTERVENTIONS. PubMed. 16(1). 138–44. 15 indexed citations
19.
Shaya, Fadia T. & Anna Gu. (2005). Assessing potential risks and evaluating expected benefits.. PubMed. 18(5). 27–30. 3 indexed citations
20.
Shaya, Fadia T., Steven W. Blume, Anna Gu, Teresa Zyczynski, & Zhanna Jumadilova. (2005). Persistence with overactive bladder pharmacotherapy in a Medicaid population.. PubMed. 11(4 Suppl). S121–9. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karl Miller Breakdown of academic impact, for papers by Jennifer Reynolds Breakdown of academic impact, for papers by Reci Meseri Breakdown of academic impact, for papers by Craig R. Bailey Breakdown of academic impact, for papers by Barbara J. Zarowitz Breakdown of academic impact, for papers by Cihan Kılıç Breakdown of academic impact, for papers by John B. Copley Breakdown of academic impact, for papers by J W Yarnell Breakdown of academic impact, for papers by Fumi Hirayama Breakdown of academic impact, for papers by Reid Whitlock
Rankless by CCL
2026